Equity Overview
Price & Market Data
Price: $2.34
Daily Change: +$0.02 / 0.85%
Range: $2.20 - $2.34
Market Cap: $4,373,200
Volume: 10,540
Performance Metrics
1 Week: 14.15%
1 Month: -5.65%
3 Months: -34.45%
6 Months: -27.78%
1 Year: -89.04%
YTD: -30.25%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Israel
Details
PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations. The company was incorporated in 2007 and is based in Tel Aviv, Israel.